biote Corp. (BTMD) Stock Analysis & Investment Frameworks
biote Corp. (BTMD) stock analysis on Invetso. Review biote Corp.’s key financial metrics, company overview and 10 institutional-grade investment frameworks including SWOT Analysis, Economic Moat, Porter’s Five Forces and the Invetso Quality Score.
biote Corp. Company Overview
- Exchange: NASDAQ Global Market
- Sector: Healthcare
- Industry: Medical - Care Facilities
- Country: US
biote Corp. Key Financial Metrics
- Market Cap: $54.25M
- Revenue: $192.22M
- P/E Ratio: 2.02
- ROE: 3.24%
- ROIC: -5.90%
- Dividend Yield: N/A
About biote Corp.
Biote Corp. is dedicated to supporting and developing medical practices that focus on hormone optimization. The company provides a comprehensive system for its Biote-certified healthcare professionals, enabling them to correct imbalances in patients' hormone, vitamin, and mineral levels. This includes authorizing the prescription of bioidentical hormone treatments and suggesting suitable dietary supplements. Furthermore, Biote offers its own line of branded nutritional supplements and supplies sterile kits for inserting hormone pellets for both male and female individuals. Founded in 2011, Biote Corp. is based in Irvine, Texas.
biote Corp. Investment Frameworks
Invetso analyzes biote Corp. (BTMD) across the following frameworks:
- biote Corp. 10Y Growth Potential
- biote Corp. Scenario Analysis
- biote Corp. Risks & Opportunities
- biote Corp. Economic Moat
- biote Corp. Business Model
- biote Corp. Management
- biote Corp. SWOT Analysis
- biote Corp. Porter's 5 Forces
- biote Corp. PESTLE Analysis
- biote Corp. ESG Analysis